Letter
Nitric oxide is not licensed for preterm neonates
Cite this as:
BMJ
2002;325:1244.2
- Charles E M Normand, head (charles.normand@lshtm.ac.uk),
- David Field, professor,
- Diana Elbourne, professor of healthcare evaluation,
- Ann Truesdale, INNOVO trial coordinator
- Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT
- Neonatal Unit, Leicester Royal Infirmary, Leicester LE1 5WW
- London School of Hygiene and Tropical Medicine
EDITOR—We agree with Pierce et al that attention should be drawn to the potential high cost of nitric oxide after the granting of its licence.1 The use of nitric oxide is not licensed for treating preterm neonates. The currently published evidence does not support the use of inhaled nitric oxide in preterm …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
Social bookmarking